Twin Securities »

ImmunoGen shares owned by Twin Securities

Quarter-by-quarter ownership of ImmunoGen shares owned by Twin Securities from 13F filings

Historical chart of Twin Securities investment in ImmunoGen

Tip: Access up to 7 years of quarterly data

All positions including ImmunoGen held by Twin Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ImmunoGen by Twin Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.6M 222k 29.65

More positions owned by Twin Securities

Karuna Therapeutics Ord
United States Steel Corporation Call Option (X)
Cerevel Therapeutics Hldng I (CERE)
stock
Endeavor Group Hldgs Cl A Com (EDR)
ImmunoGen
Kenvue (KVUE)
Pioneer Natural Resources (PXD)

View all positions for Twin Securities

Top funds holding ImmunoGen

Vanguard Group
RA Capital Management
Redmile Group
Henderson Group
Pentwater Capital Management
Fairmount Funds Management
Norges Bank Investment Management
Millennium Management
D. E. Shaw & Co
Balyasny Asset Management
Voloridge Investment Management
Boxer Capital
Maverick Capital
TIG Advisors
Tang Capital Management

View all funds holding ImmunoGen